Topical for acne vulgaris

Jan 30, 2018, 5:00am

Ortho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals.

Ortho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals. Studies have shown that the microsponge delivery system technology helps to control the release of tretinoin and improves photostability, even when used in conjunction with benzoyl peroxide, and a pump delivery system allows for controlled dispensing and consistent dosing.

The U.S. Food and Drug Administration (FDA) approved the Supplemental New Drug Application (sNDA) for RETIN-A MICRO® (tretinoin) gel microsphere 0.06% for topical application in the treatment of acne vulgaris on October 24, 2017.

FOR MORE INFORMATION: https://www.ortho-dermatologics.com